Guardian Pharmacy Services (GRDN) Files Current Report
Ticker: GRDN · Form: 8-K · Filed: Sep 18, 2025 · CIK: 1802255
Sentiment: neutral
Topics: listing, stock-exchange
Related Tickers: GRDN
TL;DR
GRDN's Class A stock is officially listed on the NYSE, effective Sept 18, 2025.
AI Summary
Guardian Pharmacy Services, Inc. (GRDN) reported on September 18, 2025, that its Class A Common Stock is listed on the New York Stock Exchange. The company, incorporated in Delaware, has its principal executive offices in Atlanta, Georgia. This filing serves as a current report under the Securities Exchange Act of 1934.
Why It Matters
This 8-K filing confirms the listing of Guardian Pharmacy Services' Class A Common Stock on the NYSE, providing transparency for investors regarding its public trading status.
Risk Assessment
Risk Level: low — This filing is a routine current report confirming stock listing and does not contain material financial or operational changes.
Key Players & Entities
- Guardian Pharmacy Services, Inc. (company) — Registrant
- GRDN (company) — Trading Symbol
- New York Stock Exchange (company) — Exchange
- September 18, 2025 (date) — Date of Report
FAQ
What is the trading symbol for Guardian Pharmacy Services, Inc.'s Class A Common Stock?
The trading symbol for Guardian Pharmacy Services, Inc.'s Class A Common Stock is GRDN.
On which exchange is Guardian Pharmacy Services, Inc.'s Class A Common Stock registered?
Guardian Pharmacy Services, Inc.'s Class A Common Stock is registered on the New York Stock Exchange.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported in this 8-K filing is September 18, 2025.
In which state was Guardian Pharmacy Services, Inc. incorporated?
Guardian Pharmacy Services, Inc. was incorporated in Delaware.
What is the principal executive office address for Guardian Pharmacy Services, Inc.?
The principal executive office address for Guardian Pharmacy Services, Inc. is 300 Galleria Parkway SE, Suite 800, Atlanta, Georgia, 30339.
Filing Stats: 511 words · 2 min read · ~2 pages · Grade level 10.7 · Accepted 2025-09-18 06:30:40
Key Financial Figures
- $0.001 — stered Class A Common Stock, par value $0.001 per share GRDN New York Stock Excha
Filing Documents
- d172478d8k.htm (8-K) — 26KB
- d172478dex991.htm (EX-99.1) — 40KB
- g172478ex99_1p10g1.jpg (GRAPHIC) — 205KB
- g172478ex99_2p11g1.jpg (GRAPHIC) — 260KB
- g172478ex99_2p12g1.jpg (GRAPHIC) — 212KB
- g172478ex99_2p13g1.jpg (GRAPHIC) — 240KB
- g172478ex99_2p14g1.jpg (GRAPHIC) — 161KB
- g172478ex99_2p15g1.jpg (GRAPHIC) — 290KB
- g172478ex99_2p16g1.jpg (GRAPHIC) — 309KB
- g172478ex99_2p17g1.jpg (GRAPHIC) — 330KB
- g172478ex99_2p18g1.jpg (GRAPHIC) — 242KB
- g172478ex99_2p19g1.jpg (GRAPHIC) — 231KB
- g172478ex99_2p1g1.jpg (GRAPHIC) — 415KB
- g172478ex99_2p20g1.jpg (GRAPHIC) — 314KB
- g172478ex99_2p21g1.jpg (GRAPHIC) — 267KB
- g172478ex99_2p22g1.jpg (GRAPHIC) — 223KB
- g172478ex99_2p23g1.jpg (GRAPHIC) — 320KB
- g172478ex99_2p24g1.jpg (GRAPHIC) — 249KB
- g172478ex99_2p25g1.jpg (GRAPHIC) — 154KB
- g172478ex99_2p26g1.jpg (GRAPHIC) — 280KB
- g172478ex99_2p27g1.jpg (GRAPHIC) — 276KB
- g172478ex99_2p28g1.jpg (GRAPHIC) — 301KB
- g172478ex99_2p29g1.jpg (GRAPHIC) — 323KB
- g172478ex99_2p2g1.jpg (GRAPHIC) — 799KB
- g172478ex99_2p30g1.jpg (GRAPHIC) — 321KB
- g172478ex99_2p31g1.jpg (GRAPHIC) — 239KB
- g172478ex99_2p32g1.jpg (GRAPHIC) — 168KB
- g172478ex99_2p33g1.jpg (GRAPHIC) — 163KB
- g172478ex99_2p34g1.jpg (GRAPHIC) — 153KB
- g172478ex99_2p35g1.jpg (GRAPHIC) — 211KB
- g172478ex99_2p36g1.jpg (GRAPHIC) — 288KB
- g172478ex99_2p37g1.jpg (GRAPHIC) — 212KB
- g172478ex99_2p38g1.jpg (GRAPHIC) — 298KB
- g172478ex99_2p39g1.jpg (GRAPHIC) — 315KB
- g172478ex99_2p3g1.jpg (GRAPHIC) — 279KB
- g172478ex99_2p40g1.jpg (GRAPHIC) — 452KB
- g172478ex99_2p4g1.jpg (GRAPHIC) — 377KB
- g172478ex99_2p5g1.jpg (GRAPHIC) — 336KB
- g172478ex99_2p6g1.jpg (GRAPHIC) — 240KB
- g172478ex99_2p7g1.jpg (GRAPHIC) — 310KB
- g172478ex99_2p8g1.jpg (GRAPHIC) — 306KB
- g172478ex99_2p9g1.jpg (GRAPHIC) — 380KB
- 0001193125-25-206771.txt ( ) — 15966KB
- grdn-20250918.xsd (EX-101.SCH) — 3KB
- grdn-20250918_lab.xml (EX-101.LAB) — 18KB
- grdn-20250918_pre.xml (EX-101.PRE) — 11KB
- d172478d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Company Presentation, dated September 18, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Guardian Pharmacy Services, Inc. September 18, 2025 By: /s/ David K. Morris Name: David K. Morris Title: Executive Vice President and Chief Financial Officer